PNC Financial Services Group
RCKT icon

PNC Financial Services Group’s Rocket Pharmaceuticals RCKT Stock Holding History

PNC Financial Services Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.1K Sell
4,988
-487
-9% -$1.69K ﹤0.01% 4048
2026
Q2 		$18.7K Sell
5,475
-2,835
-34% -$9.43K ﹤0.01% 3813
2026
Q1 		$29.7K Buy
8,310
+1,165
+16% +$4.63K ﹤0.01% 3502
2025
Q4 		$25.1K Buy
7,145
+637
+10% +$2.18K ﹤0.01% 3564
2025
Q3 		$21.2K Sell
6,508
-4,259
-40% -$13.4K ﹤0.01% 3610
2025
Q2 		$26.4K Sell
10,767
-9,897
-48% -$50.1K ﹤0.01% 3437
2025
Q1 		$138K Sell
20,664
-1,791
-8% -$17.7K ﹤0.01% 2442
2024
Q4 		$282K Buy
22,455
+6,342
+39% +$95.5K ﹤0.01% 1956
2024
Q3 		$298K Buy
16,113
+577
+4% +$11.8K ﹤0.01% 1909
2024
Q2 		$334K Buy
15,536
+768
+5% +$17.6K ﹤0.01% 1792
2024
Q1 		$398K Sell
14,768
-583
-4% -$16.6K ﹤0.01% 1679
2023
Q4 		$460K Sell
15,351
-1,495
-9% -$33K ﹤0.01% 1573
2023
Q3 		$345K Buy
16,846
+2,014
+14% +$36.6K ﹤0.01% 1735
2023
Q2 		$295K Buy
14,832
+480
+3% +$9.7K ﹤0.01% 1936
2023
Q1 		$246K Buy
14,352
+89
+0.6% +$1.74K ﹤0.01% 2011
2022
Q4 		$279K Buy
14,263
+1,955
+16% +$36K ﹤0.01% 1911
2022
Q3 		$196K Buy
12,308
+657
+6% +$10.3K ﹤0.01% 2098
2022
Q2 		$161K Buy
11,651
+3,390
+41% +$40.4K ﹤0.01% 2277
2022
Q1 		$131K Sell
8,261
-29
-0.3% -$501 ﹤0.01% 2540
2021
Q4 		$182K Sell
8,290
-347
-4% -$9.47K ﹤0.01% 2305
2021
Q3 		$259K Buy
8,637
+340
+4% +$12.4K ﹤0.01% 2023
2021
Q2 		$368K Buy
8,297
+651
+9% +$28.3K ﹤0.01% 1818
2021
Q1 		$338K Sell
7,646
-905
-11% -$49.7K ﹤0.01% 1840
2020
Q4 		$468K Sell
8,551
-429
-5% -$15.6K ﹤0.01% 1523
2020
Q3 		$206K Hold
8,980
– – ﹤0.01% 1913
2020
Q2 		$188K Sell
8,980
-620
-6% -$11.2K ﹤0.01% 1966
2020
Q1 		$134K Buy
+9,600
New +$190K ﹤0.01% 2044

Other funds holding RCKT

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

PNC Financial Services Group's RCKT Position: Q3 2026 in Review

PNC Financial Services Group reduced its Rocket Pharmaceuticals (RCKT) stake by 8.9% in Q3 2026, selling an estimated $1.69K and leaving 4,988 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4048.

PNC Financial Services Group first reported a position in RCKT in Q1 2020 and has held it in 27 quarters since. The position peaked at $468K in Q4 2020. 74 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • PNC Financial Services Group held 4,988 shares of Rocket Pharmaceuticals worth $13.1K as of Q3 2026.
  • PNC Financial Services Group sold 487 Rocket Pharmaceuticals shares in Q3 2026, an estimated $1.69K.
  • Rocket Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4048 holding.
  • PNC Financial Services Group first reported a position in Rocket Pharmaceuticals in Q1 2020 and has held it in 27 quarters since.
  • PNC Financial Services Group's Rocket Pharmaceuticals position peaked at $468K in Q4 2020.
  • 74 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.